HCA Health Inc vs Synopsys, Inc. — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while Synopsys, Inc. trades at $390 (market cap $72.47B). The key difference: HCA Health Inc and Synopsys, Inc. are close in size by market cap, and HCA Health Inc pays a 0.84% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals.
| HCA | SNPS | |
|---|---|---|
Market Cap | $82.17B | $72.47B |
Sector | Health | Technology |
52-Week High | $545.13 | $645.59 |
52-Week Low | $334.32 | $378.46 |
Enterprise Value | $131.08B | $80.82B |
Dividend Yield | 0.84% | — |
Trailing returns across standard periods
Latest headlines on both assets
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →